Stock FORTIS FORTIS HEALTHCARE LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Fortis Healthcare Limited Bombay S.E.

Equities

FORTIS

INE061F01013

Healthcare Facilities & Services

Market Closed - Bombay S.E.
Other stock markets
 03:30:50 26/04/2024 pm IST 		5-day change 1st Jan Change
443.8 INR +0.10% Intraday chart for Fortis Healthcare Limited +3.04% +5.58%
14/03 Fortis Healthcare Appoints Chief Internal Audit and Risk Officer MT
13/03 Fortis Healthcare Limited Approves the Appointment of Sanjay Baweja as Chief Internal Audit and Risk Officer CI

Valuation

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 1,02,485 95,238 1,50,350 2,19,240 1,96,214 3,34,862 - -
Enterprise Value (EV) 1 1,11,604 1,05,744 1,57,658 2,24,770 1,99,618 3,37,057 3,33,164 3,26,061
P/E ratio -36.7 x 164 x -137 x 39.5 x 33.3 x 55.3 x 40.7 x 32.3 x
Yield - - - - - 0.23% 0.28% 0.28%
Capitalization / Revenue 2.29 x 2.06 x 3.73 x 3.83 x 3.12 x 4.81 x 4.22 x 3.77 x
EV / Revenue 2.5 x 2.28 x 3.91 x 3.93 x 3.17 x 4.84 x 4.2 x 3.67 x
EV / EBITDA 49.6 x 17.3 x 39 x 20.6 x 18.1 x 27.5 x 21.6 x 17.9 x
EV / FCF -42.7 x 303 x 57.5 x 30 x 53.2 x 62.5 x 51.2 x 34.9 x
FCF Yield -2.34% 0.33% 1.74% 3.34% 1.88% 1.6% 1.95% 2.87%
Price to Book 1.55 x 1.43 x 2.46 x 3.55 x 2.71 x 4.21 x 3.82 x 3.4 x
Nbr of stocks (in thousands) 7,54,955 7,54,958 7,54,958 7,54,958 7,54,958 7,54,958 - -
Reference price 2 135.8 126.2 199.2 290.4 259.9 443.6 443.6 443.6
Announcement Date 25/05/19 17/06/20 29/05/21 25/05/22 23/05/23 - - -
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 44,694 46,323 40,301 57,176 62,976 69,640 79,379 88,936
EBITDA 1 2,252 6,095 4,044 10,931 11,013 12,252 15,419 18,181
EBIT 1 -77 3,178 1,138 7,923 7,856 8,936 11,878 14,510
Operating Margin -0.17% 6.86% 2.82% 13.86% 12.47% 12.83% 14.96% 16.32%
Earnings before Tax (EBT) 1 -1,101 2,394 432.9 9,878 8,137 8,227 11,271 14,256
Net income 1 -2,989 579.4 -1,098 5,551 5,887 6,062 8,149 10,154
Net margin -6.69% 1.25% -2.72% 9.71% 9.35% 8.71% 10.27% 11.42%
EPS 2 -3.700 0.7700 -1.450 7.350 7.800 8.017 10.91 13.74
Free Cash Flow 1 -2,616 349.4 2,740 7,501 3,750 5,395 6,509 9,347
FCF margin -5.85% 0.75% 6.8% 13.12% 5.95% 7.75% 8.2% 10.51%
FCF Conversion (EBITDA) - 5.73% 67.74% 68.62% 34.05% 44.04% 42.21% 51.41%
FCF Conversion (Net income) - 60.3% - 135.13% 63.7% 89% 79.87% 92.05%
Dividend per Share 2 - - - - - 1.013 1.254 1.246
Announcement Date 25/05/19 17/06/20 29/05/21 25/05/22 23/05/23 - - -
1INR in Million2INR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 11,770 12,524 14,103 14,625 14,666 13,781 14,878 16,072 15,599 16,427 16,574 17,668 17,349 18,040 18,677
EBITDA 1 1,904 1,973 2,752 2,844 2,869 2,276 2,511 3,029 2,764 2,709 2,725 3,328 3,142 3,420 -
EBIT 1 - 1,258 2,023 2,098 2,108 1,503 1,868 2,260 1,937 1,891 1,932 2,411 2,165 2,380 2,482
Operating Margin - 10.04% 14.35% 14.35% 14.37% 10.9% 12.56% 14.06% 12.42% 11.51% 11.66% 13.65% 12.48% 13.19% 13.29%
Earnings before Tax (EBT) - - - - - - 1,763 2,678 1,835 1,817 - 2,235 2,399 2,630 -
Net income 1 299 431.7 2,636 - - - 1,222 2,044 1,296 1,326 1,771 1,548 1,611 1,743 -
Net margin 2.54% 3.45% 18.69% - - - 8.22% 12.72% 8.31% 8.07% 10.48% 8.76% 9.29% 9.66% -
EPS - - 3.490 - - - - 2.710 - - - - 2.200 - -
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 05/02/21 29/05/21 13/08/21 12/11/21 11/02/22 25/05/22 05/08/22 11/11/22 10/02/23 23/05/23 04/08/23 - - - -
1INR in Million
Estimates

Balance Sheet Analysis

Fiscal Period: March 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 9,119 10,506 7,308 5,530 3,404 2,196 - -
Net Cash position 1 - - - - - - 1,698 8,800
Leverage (Debt/EBITDA) 4.049 x 1.724 x 1.807 x 0.5059 x 0.3091 x 0.1792 x - -
Free Cash Flow 1 -2,616 349 2,740 7,501 3,750 5,395 6,509 9,347
ROE (net income / shareholders' equity) -1.44% 0.87% -1.72% 9.03% 8.77% 7.77% 9.69% 11%
ROA (Net income/ Total Assets) -0.74% 0.5% -0.98% 4.82% 4.84% 4.67% 6.02% 7.11%
Assets 1 4,01,680 1,16,486 1,12,517 1,15,194 1,21,591 1,29,771 1,35,314 1,42,827
Book Value Per Share 2 87.40 88.20 81.10 81.80 95.90 105.0 116.0 130.0
Cash Flow per Share 2 - - - 11.50 10.90 13.50 15.80 18.50
Capex 1 831 1,366 2,115 1,153 4,472 6,378 6,450 6,287
Capex / Sales 1.86% 2.95% 5.25% 2.02% 7.1% 9.16% 8.13% 7.07%
Announcement Date 25/05/19 17/06/20 29/05/21 25/05/22 23/05/23 - - -
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Fortis Healthcare Limited

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
443.6 INR
Average target price
482.2 INR
Spread / Average Target
+8.72%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Hospitals, Clinics & Primary Care Services

1st Jan change Capi.
AIER EYE HOSPITAL GROUP CO., LTD. Stock Aier Eye Hospital Group Co., Ltd.
-20.16% 16.21B
BANGKOK DUSIT MEDICAL SERVICES Stock Bangkok Dusit Medical Services
+4.50% 12.44B
IHH HEALTHCARE Stock IHH Healthcare
+3.98% 11.58B
APOLLO HOSPITALS ENTERPRISE LIMITED Stock Apollo Hospitals Enterprise Limited
+9.72% 10.79B
RAMSAY HEALTH CARE LIMITED Stock Ramsay Health Care Limited
-2.19% 7.68B
MOUWASAT MEDICAL SERVICES COMPANY Stock Mouwasat Medical Services Company
+18.43% 7.2B
THE ENSIGN GROUP, INC. Stock The Ensign Group, Inc.
+4.49% 6.67B
GLOBAL HEALTH LIMITED Stock Global Health Limited
+50.89% 4.66B
DALLAH HEALTHCARE COMPANY Stock Dallah Healthcare Company
-5.12% 4.25B
Hospitals, Clinics & Primary Care Services
  1. Stock Market
  2. Equities
  3. FORTIS Stock
  4. FORTIS Stock
  5. Financials Fortis Healthcare Limited